Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease

Falk, 1995, Coronary plaque disruption, Circulation, 92, 657, 10.1161/01.CIR.92.3.657

van der Wal, 1999, Atherosclerotic plaque rupture—pathologic basis of plaque stability and instability, Cardiovasc Res, 41, 334, 10.1016/S0008-6363(98)00276-4

Naruko, 2002, Neutrophil infiltration of culprit lesions in acute coronary syndromes, Circulation, 106, 2894, 10.1161/01.CIR.0000042674.89762.20

Ben Chetrit, 1998, Colchicine: 1998 update, Semin Arthritis Rheum, 28, 48, 10.1016/S0049-0172(98)80028-0

Zemer, 1986, Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever, N Engl J Med, 314, 1001, 10.1056/NEJM198604173141601

Cerquaglia, 2005, Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update, Curr Drug Targets Inflamm Allergy, 4, 117, 10.2174/1568010053622984

O'Keefe, 1992, Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty, J Am Coll Cardiol, 19, 1597, 10.1016/0735-1097(92)90624-V

Hansson, 1992, Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point, Blood Press, 1, 113, 10.3109/08037059209077502

Thygesen, 2007, Universal definition of myocardial infarction, J Am Coll Cardiol, 50, 2173, 10.1016/j.jacc.2007.09.011

Hamm, 2000, A classification of unstable angina revisited, Circulation, 102, 118, 10.1161/01.CIR.102.1.118

Bhatt, 2010, Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis, JAMA, 304, 1350, 10.1001/jama.2010.1322

Schattner, 1991, Colchicine—expanding horizons, Postgrad Med J, 67, 223, 10.1136/pgmj.67.785.223

Langevitz, 2000, Prevalence of ischemic heart disease in patients with familial Mediterranean fever, Isr Med Assoc J, 2, 9

Crittenden, 2012, Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout, J Rheumatol, 39, 1458, 10.3899/jrheum.111533

Nidorf, 2007, Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease, Am J Cardiol, 99, 805, 10.1016/j.amjcard.2006.10.039

Imazio, 2005, Colchicine in addition to conventional therapy for acute pericarditis: results of the Colchicine for Acute Pericarditis (COPE) trial, Circulation, 112, 2012, 10.1161/CIRCULATIONAHA.105.542738

Kallinich, 2007, Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement, Pediatrics, 119, e474, 10.1542/peds.2006-1434

Alayli, 2005, Acute myopathy in a patient with concomitant use of pravastatin and colchicine, Ann Pharmacother, 39, 1358, 10.1345/aph.1E593

Stone, 2011, A prospective natural-history study of coronary atherosclerosis, N Engl J Med, 364, 226, 10.1056/NEJMoa1002358